These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26274392)

  • 1. Angiopoietin-2 as a Prognostic Biomarker of Major Adverse Cardiovascular Events and All-Cause Mortality in Chronic Kidney Disease.
    Tsai YC; Lee CS; Chiu YW; Kuo HT; Lee SC; Hwang SJ; Kuo MC; Chen HC
    PLoS One; 2015; 10(8):e0135181. PubMed ID: 26274392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiopoietin-2 levels predict mortality in CKD patients.
    David S; John SG; Jefferies HJ; Sigrist MK; Kümpers P; Kielstein JT; Haller H; McIntyre CW
    Nephrol Dial Transplant; 2012 May; 27(5):1867-72. PubMed ID: 21976741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
    David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
    Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of angiopoietin-2 with renal outcome in chronic kidney disease.
    Tsai YC; Chiu YW; Tsai JC; Kuo HT; Lee SC; Hung CC; Lin MY; Hwang SJ; Kuo MC; Chen HC
    PLoS One; 2014; 9(10):e108862. PubMed ID: 25279852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD.
    Tsai YC; Chiu YW; Tsai JC; Kuo HT; Hung CC; Hwang SJ; Chen TH; Kuo MC; Chen HC
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):39-46. PubMed ID: 25512646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopoietin-2, Renal Deterioration, Major Adverse Cardiovascular Events and All-Cause Mortality in Patients with Diabetic Nephropathy.
    Tsai YC; Lee CS; Chiu YW; Lee JJ; Lee SC; Hsu YL; Kuo MC
    Kidney Blood Press Res; 2018; 43(2):545-554. PubMed ID: 29642068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients.
    Liabeuf S; Lenglet A; Desjardins L; Neirynck N; Glorieux G; Lemke HD; Vanholder R; Diouf M; Choukroun G; Massy ZA;
    Kidney Int; 2012 Dec; 82(12):1297-303. PubMed ID: 22895515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations among chronic kidney disease, high total p-cresylsulfate and major adverse cardiac events.
    Wang CP; Lu LF; Yu TH; Hung WC; Chiu CA; Chung FM; Hsu CC; Lu YC; Lee YJ; Houng JY
    J Nephrol; 2013; 26(1):111-8. PubMed ID: 22460182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease.
    Inaguma D; Nagaya H; Hara K; Tatematsu M; Shinjo H; Suzuki S; Mishima T; Kurata K
    Clin Exp Nephrol; 2008 Apr; 12(2):126-131. PubMed ID: 18180871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating angiopoietin-2, its soluble receptor Tie-2, and mortality in the general population.
    Lorbeer R; Baumeister SE; Dörr M; Nauck M; Grotevendt A; Völzke H; Vasan RS; Wallaschofski H; Lieb W
    Eur J Heart Fail; 2013 Dec; 15(12):1327-34. PubMed ID: 23901057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease.
    Baek SH; Cha RH; Kang SW; Park CW; Cha DR; Kim SG; Yoon SA; Kim S; Han SY; Park JH; Chang JH; Lim CS; Kim YS; Na KY
    Tohoku J Exp Med; 2017 Aug; 242(4):281-290. PubMed ID: 28824047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients.
    Kanbay M; Siriopol D; Saglam M; Kurt YG; Gok M; Cetinkaya H; Karaman M; Unal HU; Oguz Y; Sari S; Eyileten T; Goldsmith D; Vural A; Veisa G; Covic A; Yilmaz MI
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1854-61. PubMed ID: 25057883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin K intake and mortality in people with chronic kidney disease from NHANES III.
    Cheung CL; Sahni S; Cheung BM; Sing CW; Wong IC
    Clin Nutr; 2015 Apr; 34(2):235-40. PubMed ID: 24745600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating angiopoietin-2 levels increase with progress of chronic kidney disease.
    David S; Kümpers P; Lukasz A; Fliser D; Martens-Lobenhoffer J; Bode-Böger SM; Kliem V; Haller H; Kielstein JT
    Nephrol Dial Transplant; 2010 Aug; 25(8):2571-6. PubMed ID: 20179005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. J-shaped mortality relationship for uric acid in CKD.
    Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
    Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of laser Doppler flowmetry tests, serum angiopoietin-2, asymmetric and symmetric dimethylarginine to predict outcome in chronic kidney disease.
    Nemcsik J; Cseprekál O; Egresits J; Kielstein J; Kümpers P; Lukasz A; Tabák Á; Marton A; Németh ZK; Járai Z; Godina G; Sallai L; Farkas K; Kiss I; Tislér A
    J Hypertens; 2017 May; 35(5):1109-1118. PubMed ID: 28106663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble TWEAK and cardiovascular morbidity and mortality in chronic kidney disease patients.
    Hassan SB; El-demery AB; Ahmed AI; Abukhalil RE
    Arab J Nephrol Transplant; 2012 Jan; 5(1):27-32. PubMed ID: 22283863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Xanthine Oxidase Activity Is Predictive of Cardiovascular Disease in Patients with Chronic Kidney Disease, Independently of Uric Acid Levels.
    Gondouin B; Jourde-Chiche N; Sallee M; Dou L; Cerini C; Loundou A; Morange S; Berland Y; Burtey S; Brunet P; Guieu R; Dussol B
    Nephron; 2015; 131(3):167-74. PubMed ID: 26426087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of spironolactone on the risks of mortality and hospitalization for heart failure in pre-dialysis advanced chronic kidney disease: A nationwide population-based study.
    Tseng WC; Liu JS; Hung SC; Kuo KL; Chen YH; Tarng DC; Hsu CC
    Int J Cardiol; 2017 Jul; 238():72-78. PubMed ID: 28363684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Levels of Renalase, the β-NAD(P)H Isomerase, Can Be Used as Risk Factors of Major Adverse Cardiovascular Events and All-Cause Death in Patients with Chronic Kidney Disease.
    Knop W; Serwin NM; Cecerska-Heryć E; Grygorcewicz B; Dołęgowska B; Gomółka A; Wiśniewska M; Ciechanowski K
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.